Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Asia Pacific

Set Alert for Asia Pacific

Market Brief: Looking Beyond China And Japan For High Growth And Opportunity In Asian Medtech

With a combined value of $14.1bn in 2019, there are ten high-growth medtech markets worth watching in Asia.

Asia Pacific Medical Device Emerging Markets

Global Medtech Guidance Tracker: November 2019

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-eight guidance documents have been posted on the tracker since its last update.

International India

How The Rest Of The World Is Reeling From The EU's Regulatory Upheaval

Medtech consultant Arthur Brandwood explains why the EU’s medtech regulations are sending shockwaves through so many other countries, and why CE marking may be unlikely to return to its previous position as the preeminent international certification.

Europe EU

Global Medtech Guidance Tracker: October 2019

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-seven guidance documents have been posted on the tracker since its last update.

International Europe

Pakistan Tightens Safety Surveillance For Devices

A new guidance document explains how Pakistan’s revamped therapeutic product surveillance system will work.

Pakistan Regulation

Scrutiny In Store For Hong Kong’s First Advanced Therapy Rules

Requirements for advanced therapies in Hong Kong are being modeled on the EU regulatory regime.

Regenerative Medicine Hong Kong

Clarity Sought On Which Spinal Implants Will Escape Up-Classification In Australia

Australia’s Therapeutic Goods Administration is pressing on with plans to move certain spinal implant devices from class IIb to the higher-risk class III.

Australia Orthopedics
See All

UsernamePublicRestriction

Register